(Q36542815)

14 August 2017

Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project (English)

1 reference

14 August 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

Richard C Harvey

3

0 references

Malcolm A Smith

object named as

Malcolm Smith

22

0 references

Charles G. Mullighan

object named as

Charles G Mullighan

25

0 references

Stephen P Hunger

26

object named as

Stephen P Hunger

1 reference

14 August 2017

24

Cheryl L Willman

1 reference

14 August 2017

20

Naomi Winick

1 reference

14 August 2017

16

Meenakshi Devidas

1 reference

14 August 2017

1

Mignon L Loh

1 reference

14 August 2017

10

Michael Edmonson

1 reference

14 August 2017

9

Jared Becksfort

1 reference

14 August 2017

21

Elizabeth Raetz

1 reference

14 August 2017

15

Michael J Borowitz

1 reference

14 August 2017

18

Paul Bowman

1 reference

14 August 2017

6

Huining Kang

1 reference

14 August 2017

14

Brent Wood

1 reference

14 August 2017

11

Kenneth H Buetow

1 reference

14 August 2017

17

Daniela S Gerhard

1 reference

14 August 2017

5

Debbie Payne-Turner

1 reference

14 August 2017

Jinghui Zhang

2

1 reference

14 August 2017

Kathryn Roberts

4

1 reference

14 August 2017

Gang Wu

7

1 reference

14 August 2017

Xiang Chen

8

1 reference

14 August 2017

William L Carroll

12

1 reference

14 August 2017

I-Ming Chen

13

1 reference

14 August 2017

Eric Larsen

19

1 reference

14 August 2017

James R Downing

23

1 reference

14 August 2017

language of work or name

English

0 references

publication date

4 December 2012

1 reference

14 August 2017

1 reference

14 August 2017

121

1 reference

14 August 2017

485-488

1 reference

14 August 2017

3

1 reference

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

JAK mutations in high-risk childhood acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

SNPdetector: a software tool for sensitive and accurate SNP detection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Diagnosis of multiple cancer types by shrunken centroids of gene expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3548168

10.1182/BLOOD-2012-04-422691

4 December 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

1 reference